The Royal Pharmaceutical Society (RPS) has published Pharmacy: Delivering a Healthier Wales that outlines a plan focusing on what can be achieved by end of 2025.
The society has urged people to share their views by responding to the consultation on four key themes which were already set out in Pharmacy: Delivering a Healthier
Wales -enhancing patient experience; developing the pharmacy workforce; seamless pharmaceutical care; and harnessing innovation and technology.
"We want to hear from as many of you as possible. It is important that the aims for pharmacy over the next three years are right. So please take a look at the draft
2025 goals, the proposed activity and measures and complete our consultation response form by 11 September," said RPS.
"We have been proud to continue to manage this important ambition for Wales, working on behalf of the Welsh Pharmaceutical Committee and with colleagues from all
over Wales. Over 300 of you have already contributed to our face to face and virtual engagement sessions we held over the past three months and we thank you for your
valuable input.
Since the introduction of the 2019 NHS Long-Term Plan, several policy commitments have surfaced, presenting a definitive 'blueprint' for community pharmacy
in England. The Company Chemists Association has identified four crucial commitments that, when integrated, hold the potential to revolutionise patient care
through community pharmacies.
"Each commitment is like a crucial piece of a puzzle," CCA said. "For the transformation of patient access through community pharmacy to be successful, all these
pieces must come together harmoniously. Otherwise, the picture will remain incomplete."
The four major pieces of the puzzle coined by CCA include:
* Building on education and training reforms to increase the size and capability of the workforce.
* Expanding the number of clinical services commissioned and delivered in community pharmacy.
* Introducing digital enablers which underpin service delivery.
* Introducing legislative changes to increase capacity and allow the delivery of more patient-facing clinical care.
Responding to a new National Audit Office (NAO) report that indicated that NHS England's Long Term Workforce Plan (LTWP) needs improvements, the Royal
College of General Practitioners (RCGP) has expressed concerns that the plan may not adequately address the needs of GPs.
Published in June 2023, the workforce plan estimated that the NHS's health workforce will need to grow from 1.4m full-time equivalent (FTE) staff in 2021-22 to
between 2.3m and 2.4m FTE workers in 2036-37, an increase of 65 per cent to 72 per cent.
However, the NAO report highlighted that the workforce modelling has significant weaknesses, including a complex design; manual adjustments; optimistic future
assumptions and limited public communication of their uncertainty; and modelling outputs that could not be fully replicated.
To improve the modelling, the report recommended exploring the uncertainty of these assumptions and considering potential outcomes if they do not materialize as
expected. Additionally, it suggested including full integration of the different parts of the modelling pipeline to minimise manual adjustments.
Community pharmacies will be able to deliver approximately 15 million blood pressure screenings by 2026, revealed the Company Chemists' Association (CCA)'s new
research.
This will also prevent 15,000 people from suffering heart attacks or strokes. CCA has called the Government to take up their offer and commission pharmacies as the
first port of call for cardiovascular care.
"Thousands of lives can be saved with ambitious commissioning and the investment to match," said CCA.
There is an opportunity to use the expertise of community pharmacy to go further and provide the care these newly identified patients' need. To do this the sector
needs funding and workforce.
The association said: "Community pharmacy is under great financial pressure, suffering a real term funding cut of over 30% over 8 years. With funding, the sector can
transform to deliver this critical need for patients.
Whilst there are plans to train Independent Prescribers (IPs), there are no clear roles for them to use these skills. There is a need to accelerate training plans to
allow pharmacists to deliver the service described here and play their part in CVD management."
Day Lewis Pharmacy has enlisted Locate a Locum, a Belfast-based healthcare technology innovator, to deploy and manage a digital solution aimed at enhancing
locum staffing and management across its 267-pharmacy network.
"We sought a faster, user-friendly system for instant locum bookings, particularly for last-minute shifts," said Sam Patel, Executive Director at Day Lewis
Pharmacy. "This tool improves communication between potential locums and our coordinators, creating more opportunities to attract talent from across the country.
Our customers are our priority, and ensuring they have access to staff and advice when needed is our main focus."
Locate a Locum will implement a cloud-based digital solution across the Day Lewis Pharmacy estate, allowing locums to securely search, manage, request, and receive
payment for shifts, Day Lewis said in a statement. This platform enables locum staff to manage their work diaries, location preferences, and commitments, promoting
balanced work-life planning.
"The Locate a Locum platform allows for swift, complete payments to our locums and offers them instant booking, eliminating the need for shift confirmation wait
times," Patel added. "In a dynamic market with rising demand for pharmacy services, this platform is a game-changer, driving growth and unlocking potential."
The NHS plans to train hundreds of pharmacy staff, expanding their ability to provide advanced clinical services and assume wider roles in dispensing medicines.
With a targeted launch in September, up to 840 pharmacy technicians can join in the training programme. The online modules will cover consultation skills,
therapeutics, clinical decision-making, assessment skills, and service improvement.
"Community pharmacies are pivotal in local communities, and this novel training scheme empowers them to extend their service offerings to a wider patient base,"
said Health Minister Neil O'Brien. "Through our investment in the workforce, we're bolstering the implementation of the Pharmacy First initiative with £645 million,
ensuring patients have access to expert assistance for various common ailments, including urinary tract infections and earaches."
NHS said the training will offer flexibility to align with the working schedules and prior experience of community pharmacy technicians. It will combine independent
online e-course study, educational supervision, and clinical skills training. Facilitated workshops will concentrate on enhancing clinical assessment skills and
applying knowledge and skills through case studies, practice activities, and group discussions.
The hybrid professional and leadership session underscores the Sigma Conference's significance in offering hope and inspiration to its delegates. This
pioneering venture unfolds following meticulous planning, months of deliberation, and the collaboration of experts from various health disciplines across the UK.
This session, rich in diversity and expertise, aims to elevate the role of community pharmacy in the ever-evolving landscape of the NHS.
It comprises three key components and delves into multi-professional collaboration, insights from NHS Chief Professional Officers from the four devolved nations
complimented by the Royal College of Nursing Directorate Wales, and the evolving landscape of Pharmacy Professional Leadership.
Multi-Professional Collaboration: Breaking Boundaries
The crux of this ground-breaking session lies in appreciating and fostering greater multi-professional collaboration to set the stage for a thought-provoking
session on how community pharmacy can be recognised as an important cog in the wheel of an integrated NHS. This convergence creates a dynamic platform for community
pharmacy to form wider partnerships and explore opportunities, particularly with the recently launched NHS Pharmacy First Service.
Titan PMR, a pioneer of cutting pharmacy technology has set up additional new team of 12 staff to cater for a deluge of independent pharmacists investing in
new businesses.
The company is utilising the opportunity that is underway as large chains look to sell off or close their community pharmacies, offering an opportunity for
pharmacists looking to provide efficient dispensing and additional services.
In January this year Lloyds Pharmacy, which was bought by a private equity firm in 2022, announced plans to close all its 237 branches inside Sainsbury's stores over
the course of 2023. Currently, more than 5,500 of around 14,000 registered pharmacy premises across the UK are owned by corporates and supermarkets.
Titan PMR - an innovative, cloud-based system which manages end-to-end pharmacy workflow - has become the preferred software platform especially amongst first time
buyers who are keen to offer new services to patients. The new team at the Bristol-based company, hired to support this sector, sees its total workforce growing to
more than 50 staff.
Workforce issues, staff retention and capacity continues to be a big concern for the Local Pharmaceutical Committee as it discussed the topics at a recent meeting with the Pharmaceutical Services Negotiating Committee (PSNC).
The meeting, attended by delegates from 66 LPCs, focused on the current challenges faced by community pharmacies as well as the planning for the next year.
Around 64 per cent of delegates said workforce was the top challenge faced by pharmacy contractors, and suggested reducing the migration of pharmacists to Primary Care Networks (PCNs).
Other suggestions included - "improving the development opportunities available for pharmacists and their teams, and rebranding the profession to make community pharmacy a more attractive route for young graduates."
On the development of Integrated Care Systems (ICS), the majority of respondents were positive about their LPC's engagement in the new setting.
The Department of Health has published 'A Guide to Developing the Role of Consultant Pharmacists' in Northern Ireland on Thursday (22 June).
The guidance provides direction on supporting a consistent approach to the introduction of senior clinical pharmacy roles within and across HSC organisations.
The Chief Pharmaceutical Officer Professor Cathy Harrison said: "There is a recognised need for increased clinical pharmacy and medicines focussed leadership
across our HSC."
"Consultant Pharmacists have an essential role in healthcare as clinicians and as leaders who make a significant impact to medicines optimisation and clinical
governance, providing a vital link between clinical practice and service development by generating and disseminating evidence to drive improvements in care.
"I am delighted that this guidance has been published to take forward the strategic development and appointment of the consultant pharmacy workforce in both
primary and secondary care and to enable pharmacy to be at the forefront of healthcare in NI".
The Royal Pharmaceutical Society (RPS) has called for urgent action to ensure wellbeing of pharmacists after the publication of its annual workforce survey.
The survey, conducted in partnership with the charity Pharmacist Support, revealed that 89 per cent of respondents were at high risk of burnout, showing ongoing high levels of workplace stress.
It stated that 57 per cent of respondents reported often being unable to take a rest break or were not offered a break at all.
Around 68 per cent noted weakening of their mental health and wellbeing due to work or study, and 33 per cent considered leaving the profession, indicating high
percent levels of disaffection.
Besides seeking urgent action to allow proper rest breaks for pharmacists, RPS has sought "governments, the NHS and employers to urgently address the workforce issues that are impacting pharmacists' wellbeing."
It said prioritising essential work, effective workforce planning and better access to information is needed.
Commenting on the survey report, RPS president Professor Claire Anderson said: "Our survey demonstrates the continued pressure on pharmacists and trainees across the workforce".
Now is the best time for community pharmacy to integrate its model of NHS representation and support to ensure better outcomes for contractors, said James Wood, director of Contractor & LPC Support, Pharmaceutical Services Negotiating Committee (PSNC).
It is important for the sector to adapt to the new landscape and address challenges such as workforce, digital data, integration of pharmacy services, and medicines optimisation, he said during the first session of the sixth annual Pharmacy Business Conference held online on Tuesday, September 21.
Under the new system, every part of England will be covered by integrated care systems (ICSs) from April 2022. ICSs have been created to bring about big changes in how health and care services in England are planned, paid for and delivered. They are a key part of the direction of travel for the NHS as outlined in the NHS Long Term Plan.
The NHS England last week released a survey report on the involvement of pharmacy professionals in research, and proposed the implementation of a
clinical academic training pathway for pharmacy professionals by 2030.
Recommendations were made to support the embedding of research at all stages of a pharmacy professional's career.
The report presented the findings of two surveys that NHS England launched in May 2022, one for individual pharmacy professionals and one for organisations,
calling for evidence on clinical academic careers in pharmacy.
The survey found that only a minority of the pharmacy workforce take up clinical research training opportunities.
"Just under a quarter of individual respondents had applied for the National Institute of Health and Care Research (NIHR) or other research project grants, and
just under half of the organisational survey respondents had supported individuals to apply for such a grant," it said.
The government has allocated an additional 350 medical school places in England, making a significant step in delivering the NHS Long Term Workforce Plan.
Supported by more than £2.4 billion in government funding, the plan outlines the strategy for recruiting and retaining hundreds of thousands more staff over the
next 15 years to deliver the future workforce the NHS requires.
One of the key commitments of the NHS Long Term Workforce Plan is to double the number of medical school places in England to 15,000 by 2031.
As part of the ongoing efforts to fulfill this pledge, the Office for Students (OfS) has designated 350 places for medical schools nationwide for the academic year
2025 to 2026, targeting under-doctored areas.
Pharmacy bodies are "bitterly disappointed" that the latest deal on the national contract makes no commitment to "fresh funding", with one organisation calling
it "the biggest dis-service ever done" to community pharmacy.
The only commitment made in monetary terms was one in which NHS England agreed to write off a sum of £100m in excess margin earned by contractors in previous years.
This allowance, which can't be seen as new cash injection, was said to have been made in recognition of the pressures facing the sector.
The figure - reached after what the the Pharmaceutical Services Negotiating Committee called "a tense period of negotiations" with the Department of Health and Social
Care and NHS England - will cover the final two years of the current five-year Community Pharmacy Contractual Framework.
The deal was announced by PSNC chief executive Janet Morrison at an annual LPC Conference in Manchester on Thursday (22 September). Welcoming the attendees, she
assured everyone that the committee was well aware of the pressures the sector was facing.
"I heard how contractors are feeling and their frustrations over growing pressure and lack of financial support from the government. They confirmed that many now
are unable to deliver the full range of services, and others are struggling to maintain core levels of services. And the ongoing impact of capacity and workforce
crisis is critical, leading to temporary closures.
The International Pharmaceutical Federation (FIP) has offered a new resource to help countries self-assess readiness of their regulations to enable
pharmacist-delivered vaccination services and, where needed, to implement such regulations.
Developed by FIP's Regulators Advisory Group, it covers broad pharmacist-led roles related to vaccination from supply chain management to administration and
prescribing.
"This new resource from FIP is based on the experiences of professional regulators in countries where pharmacy-led vaccination has been successfully introduced
and regulated. With it, we aim to support regulators, policymakers and national organisations in developing strategies or enabling regulatory frameworks in
countries where the pharmacy workforce has a limited role in vaccination strategies so that it can contribute further to the global imperative of improving
immunisation coverage," said Brett Simmonds, group chair.
The "Pharmacy-led vaccination services: Regulatory self-assessment and implementation tool" aims to help identify strengths and areas for improvement in order to
inform vaccination policy and planning efforts.
The Pharmacists' Defence Association has asked Boots UK to waive any restrictive clause that prevents pharmacists working with the multiple from working for other pharmacy employers, even after leaving the company.
However, the firm is yet to respond to the formal request, PDA said in an update.
This request follows demand from the association members shortly after the company announced it's plans to cut opening hours.
On workforce shortages, the PDA stated if there was a genuine shortage, then preventing pharmacists from working for other pharmacy employers to make up for the lost hours would be counterproductive and it would further exacerbate any "shortage".
National pharmacy bodies have welcomed two VAT changes related to community pharmacy services announced in the Spring budget on Wednesday (15 March) but were
disappointed that the budget brought no further relief for the sector in a crippling funding crisis.
It was announced that from 1 May 2023, VAT exemption on healthcare would be extended to include medical services carried out by staff directly supervised by
registered pharmacists.
The government will also extend zero rate on prescriptions to medicines supplied through Patient Group Directions. This measure will be introduced in autumn 2023.
HM Treasury said these measures were being introduced to ensure that the VAT system keeps up with changes to how the NHS operates and how healthcare is delivered
across the country.
More widely, Chancellor Jeremy Hunt promised to halve inflation and said that the NHS would soon publish its long-term workforce plan.
As the countdown to the next UK election begins, the King's Fund has identified three priorities to improve public health.
The national action would be taken by the future government to fix the "NHS and social care" in the country.
The health policy think tank said it would prioritise "improving access to out-of-hospital care", making "careers in health and social care" more attractive
and tackling the biggest risk factors affecting people's health.
It highlighted that workforce crisis is one of the biggest challenges faced by the National Health Service (NHS) and social care services in England while
citing "years of poor planning and fragmented responsibilities" as the reason for widespread staff shortages.
As per the King's Fund's data, there were more than 125,000 vacancies across the NHS workforce in England in October 2023, not including primary care vacancies
such as GPs, and 152,000 vacant posts in the adult social care workforce.
The Pharmaceutical Services Negotiating Committee (PSNC) has refused to accept the Department of Health and Social Care (DHSC)'s decision to get rid of
'transitional payments' from February 2023.
The pharmacy negotiator said that 'any reductions in payments at this point will be impossible for community pharmacy contractors to manage financially.'
"We are also continuing to be clear with officials and ministers that CPCF funding needs an urgent uplift to help businesses to cope with soaring costs being driven
by inflation and the workforce crisis. We put a comprehensive business case to the government for this uplift in the last CPCF negotiations."
The latest 'transitional payments decision' by the Department follows the announcement last year that the value of the these payments would be phased down over the
second half of 2022/23 and will be based on the latest monitoring and analysis of funding delivery.
PSNC says it submitted a fully-costed bid for a 'Pharmacy First' service in its last round of negotiations alongside the case for an uplift to core CPCF funding.
Both of these were refused.